Related Experiment Video
Updated: Nov 1, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
[Progress in immune regulation involving exosomes in hypoxic tumor microenvironment]
Linlin Wang1, Guiquan Zhu2, Ling Li3
1Sichuan Cancer Hospital & Sichuan Key Laboratory of Radiation Oncology, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
Abstract:
Hypoxia is a key characteristic of solid malignant tumor microenvironment. Exosomes secreted by tumor cells as well as stromal cells are important components of the tumor microenvironment. Hypoxia regulates the formation, contents loading, release and biological functions of exosomes. In the hypoxic microenvironment, tumor cell-derived exosomes can deliver important differentially-expressed molecular cargoes to a variety of immune cells and regulate these cells activity to facilitate the growth of tumors by inducing M2 polarization of macrophages, expansion of regulatory T cells, activation of myeloid-derived suppressor cells, and inhibition of cytotoxicity in natural killer cells. To elucidate the interaction mediated by exosomes between tumor cells and immune cells under hypoxia tumor microenvironment and the underlying mechanisms by which exosomes regulate anti-tumor immunity will provide reference for the application of exosomes in tumor vaccines, anti-cancer drug delivery and combined immunotherapy.
Related Concept Videos
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Regulation of Hematopoietic Stem Cells
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

